URINALYSIS AND OTHER BODY FLUIDS - Comprehensive Study Notes (Lecture Transcript Summary)
A. Safety and Quality Assessment in the Laboratory
The clinical laboratory contains multiple safety hazards capable of causing serious injury or life-threatening disease.
Staff must know hazards, apply basic safety precautions, and follow common-sense rules for patients, coworkers, and themselves.
Safety procedure manuals must be readily available and describe policies mandated by:
Centers for Disease Control and Prevention (CDC)
L Occupational Safety and Health Administration (OSHA)
Clinical and Laboratory Standards Institute (CLSI) – provides guidelines for writing procedures.
Types of safety hazards:
A. Biological Hazard – Potentially harmful microorganisms
Chain of Infection (COI): transmission of microorganisms; essential to prevent spread of infection; requires a continuous link between Source → Mode of Transmission → Susceptible host.
The best way to break COI is Hand washing.
Hand washing procedure:
Wet hands with warm water
Apply antimicrobial soap
Rub to lather, create friction, clean between fingers and under nails for at least 20 seconds; include thumbs and wrists
Rinse hands downward to prevent recontamination
Dry with paper towel
Turn off faucets with a clean paper towel to avoid recontamination
Personal Protective Equipment (PPE):
Gloves
Fluid-resistant gowns
Eye and face shields
Countertop shields
Hand contact is the primary method of infection transmission.
Disposal of biological wastes:
All biological waste except urine must be placed in containers labeled with the biohazard symbol.
Urine disposal: pour into laboratory sink, avoid splashing, flush with water, and daily disinfection of the sink with a 1:5 or 1:10 dilution of sodium hypochlorite. Prepare 1:10 NaOCl by mixing 1 part bleach to 9 parts water.
Sharp hazards: disposed in puncture-proof, resistant containers (needles, lancets, broken glassware).
Chemical hazards: if spills occur, first aid includes flushing area with large amounts of water for at least 15 minutes; do not neutralize skin-contact chemicals. Wear goggles; work under a fume hood. Hazard logos (examples):
NFPA hazard diamond (Yellow: Reactivity, Blue: Health, Red: Flammability, White: Special)
Yellow quadrant indicates reactivity/stability; numbers 0–4 indicate hazard level.
White quadrant codes: OX, ACID, COR (alkali), NO WATER, RADIATION, etc.
Fire hazards:
Store flammable chemicals in safety cabinets and explosion-proof refrigerators in remote areas.
If clothing catches fire, wrap in blanket to smother flames.
Use the RACE technique for fires: Rescue, Alarm, Contain, Evacuate/Extinguish.
Use PASS technique to operate a fire extinguisher: Pin, Aim, Squeeze, Sweep.
Fire extinguisher types by class (A–K) and suitable extinguishing media.
Electrical hazards:
Do not operate equipment with wet hands; ensure equipment is grounded (three-pronged plugs).
In case of shock, power down via circuit breaker or unplug with a non-conductive object; do not touch the person.
Fire safety and physical hazards are complemented by general precautions (no running, watch wet floors, bend knees when lifting, tie back long hair, remove jewelry, keep area clean, wear closed-toe shoes).
B. Safety and Quality Assurance in Urinalysis and Body Fluids
I. Safety – Personal Protection, Waste, and Hazard Management
PPE: gloves, fluid-resistant gowns, eye/face shields, countertop shields.
Hand hygiene is the primary infection control measure; reinforce training.
Waste disposal: segregate biohazard waste; urine disposal specifics; sink disinfection with a 1:10 NaOCl; label and contain sharp wastes properly.
Chemical safety: recognize NFPA hazard coding; avoid skin contact with concentrated reagents; consult MSDS for spills; work under hood for volatile or corrosive substances.
Fire and electrical safety: follow RACE and PASS; ensure electrical equipment is grounded; know emergency procedures.
II. Quality Assurance (QA) in Urinalysis and Body Fluids
QA types:
1) Pre-analytical: specimen collection, labeling, type, volume, container, transport, and specimen rejection criteria.
2) Analytical: reagent quality, instrument calibration, performance checks, preventive maintenance.
3) Post-analytical: standardized reporting, reference intervals, critical/panic values.Pre-analytical details:
Specimen containers: appropriate capacity, sterile/opaque as required.
Minimum labeling: patient name, date/time collection.
Rejection criteria: unlabelled containers, non-matching labels, contaminated specimens, insufficient volume, improper transport/preservation, and delays between collection and receipt.
Specimen processing: immediate processing (within ~2 hours for routine UA) to preserve integrity and TAT; for timed specimens, adequate mixing, volume measurement, and aliquoting.
Analytical QA specifics:
Reagents: deionized water for reagent prep; check pH/purity weekly; bacterial counts monthly; reagent strips stored in opaque containers with desiccant at room temperature; run positive and negative controls every 24 hours.
Equipment: routine performance checks, calibration, preventive maintenance; e.g., centrifuge rotor and interior cleaned daily/weekly; speed/timer checked every 3 months; microscopes cleaned daily; annual preventive maintenance.
Quality Control (QC):
Internal QC: two levels of commercial controls; run at shift start and after reagents changes or instrument faults; data retained for 2 years; reviewed daily/monthly for errors.
External QC/Proficiency testing: participate in external programs; use lyophilized or ready-to-use specimens from regulatory bodies.
Post-analytical QA: reporting and interpretation of results using standardized formats; include reference values; for urine microscopy, quantitate an average of 10 fields under both low and high power; certain elements (budding yeast, mycelia, trichomonas, mucus threads, sperm) are not quantitated.
III. Introduction to Urinalysis
Key points:
Urine is readily available and easily collected; contains information obtainable by inexpensive tests.
Basic urinalysis comprises gross examination and dipstick analysis for substances such as blood, leukocytes, glucose, and other analytes.
Microscopic analysis of urine detects cellular elements, casts, and crystals; sometimes automated systems can perform this.
Red blood cells in urine (RBCs) can originate anywhere in the urinary tract; dysmorphic RBCs suggest glomerular disease.
The first-void morning urine is typically the most concentrated and often best for analysis.
12- or 24-hour urine samples may be required for specific procedures.
Glomerular filtration and concentrating ability are reflected by specific gravity and osmolality.
Proteinuria (>4 g/day) is typical of nephrotic syndrome; ketonuria occurs in certain metabolic states; ketone tests have broader clinical implications.
Dipstick nitrite and leukocyte esterase tests aid diagnosis of UTIs; positive results should be confirmed by microscopy.
Urine screening for metabolic disorders includes detection of aminoacidurias, porphyrias, and organic acidemias via dipstick-like and specific confirmatory tests.
C. Basic Examination of Urine
I. Urine Consideration
Urine composition: Water 95–97%, Solids 3–5% (TS 60 g/day).
Organic components (major): urea (40–50%), creatinine, uric acid, hippuric acid, ammonia, mucins, enzymes, hormones.
Inorganic components (major): chloride, sodium, potassium, calcium, phosphate, sulfate, magnesium; NaCl is a principal salt.
Types of urine collection: first morning, random, timed specimens (24-hour, 12-hour, postprandial, etc.), fasting/second morning, midstream clean-catch, catheterization, suprapubic aspiration.
24-hour urine collection specifics:
Begin/end with empty bladder; require preservatives; discard first morning specimen; collect subsequent voids for 24 hours.
24-hour urine examples: creatinine clearance, urine metabolites.
Prostate-specific specimen collection (three-glass collection) for prostatitis: VB1 first void, VB2 midstream, VB3 post-massage; compare WBCs/Bacteria across portions; PPMT protocol details provided.
II. Urine Formation and Renal Physiology (Key Pathways)
Order of urine formation:
Glomerulus: highly specialized capillary tuft inside Bowman’s capsule; non-selective filtration of plasma with molecular weight < 70,000 Da; glomerular filtrate lacks proteins and fats; ultrafiltrate of blood.
Proximal Convoluted Tubule (PCT): major site of water and electrolyte reabsorption; secretion of sulfates, glucuronides, hydrogen ions, and certain drugs.
Loop of Henle: descending limb reabsorbs water (solutes not reabsorbed); ascending limb reabsorbs solutes; water-impermeable to solutes.
Distal Convoluted Tubule (DCT): final sodium reabsorption with aldosterone; maintains water and electrolyte balance; acid-base balance via hydrogen ion removal.
Collecting Duct: final urine concentration; regulated by ADH.
Calyx, Renal Pelvis: urine routed toward ureter.
Renal function components:
Renal Blood Flow (RBF): ~1200 mL/min
Renal Plasma Flow (RPF): ~600–700 mL/min
Glomerular Filtration Rate (GFR): ~120 mL/min in healthy adults
Regulatory systems:
Renin-Angiotensin-Aldosterone System (RAAS): maintains nephron pressure and renal blood flow via juxtaglomerular apparatus (JGA)
Juxtaglomerular apparatus: detects changes in blood pressure and plasma Na; renin converts angiotensinogen to angiotensin I; ACE (in lungs) converts to angiotensin II; angiotensin II promotes vasodilation of the afferent arteriole, vasoconstriction of the efferent arteriole, and stimulates proximal sodium reabsorption; aldosterone and ADH promote Na+ and water reabsorption.
Tubular reabsorption and secretion:
Primary active transport vs passive diffusion.
Antidiuretic hormone (ADH/AVP): regulates water reabsorption in DCT and collecting ducts; produced in hypothalamus; secreted by posterior pituitary in response to high plasma osmolality.
Osmolality and osmoregulation:
Normal serum osmolality: ~275–295 mOsm/kg; 24-hour urine osmolality: ~300–900 mOsm/kg.
Direct osmolality measurement methods: freezing point osmometry or vapor pressure osmometry; indirect calculation for serum only.
III. Renal Evaluation Tests
Clearance tests measure filtration/concentration/secretion capabilities; common substances include urea, creatinine, inulin (gold standard exogenous), B2-microglobulin, radiolabeled isotopes, and cystatin C.
Endogenous clearance examples:
Urea clearance (not ideal due to tubular reabsorption)
Creatinine clearance (best practical estimate of GFR)
Inulin clearance (gold standard for GFR in research; not routine clinical use)
General formula for clearance (example: creatinine clearance):
Where: $U{cr}$ = urine creatinine concentration, $V$ = urine volume per unit time, $P{cr}$ = plasma creatinine concentration.
Commonly used endogenous formula: Cockcroft-Gault equation (estimates creatinine clearance to approximate GFR):
Reference ranges and interpretation:
Males: ~107–139 mL/min; Females: ~87–107 mL/min (adjusted for body size and age).
Tubular reabsorption and secretion tests (examples): PAH test for secretion and renal plasma flow; PSP (obsolete).
Tubular and glomerular tests are complemented by measurement of specific gravity and osmolality, using formulas and reference values described in the dipstick and laboratory methods.
IV. Urinalysis – Chemical Examination (Reagent Strips)
Reagent strips provide semi-quantitative results for multiple analytes: pH, protein, glucose, ketones, blood, bilirubin, urobilinogen, nitrite, leukocyte esterase, and specific gravity.
Usage notes:
Dip strip fully; remove excess urine by tapping strip edge; wait the specified time; compare to color chart under good light.
Reagent strips from different manufacturers are not interchangeable.
Revert refrigerated specimens to room temperature before testing.
Do not allow strips to stay in urine for too long; avoid strip contamination.
pH (pH indicator system):
Principle: double-indicator system; time ~60 seconds; color: orange (pH 5) to blue (pH 9).
Clinical significance: helps assess acid-base disorders and urine conditions requiring specific pH (e.g., uric acid crystallization).
Protein (Sorensen’s) – proteinuria as a renal disease indicator:
Time: ~60 seconds; color: blue.
Normal urine protein: < 10 mg/dL or < 150 mg/dL in a 24-hour sample; major protein is albumin; tests differentiate pre-renal, renal, and post-renal proteinuria.
Types of proteinuria:
Prerenal/Overflow proteinuria (e.g., multiple myeloma Bence Jones protein)
Renal proteinuria (glomerular or tubular origin)
Post-renal proteinuria (from urinary tract sources)
Glucose:
Principle: enzymatic (glucose oxidase) or copper reduction (Clinitest) tests; renal threshold for glucose ~
Glycosuria causes: diabetes mellitus, pancreatitis, pregnancy, nephrotic syndrome, etc.; tubular reabsorption defects (Fanconi syndrome) also cause glucosuria with normal plasma glucose.
Clinitest detects reducing substances (not specific for glucose alone).
Ketones:
Principle: sodium nitroprusside reaction (Legal’s test) – detects acetoacetate and acetone; beta-hydroxybutyrate not well detected.
Significance: ketonuria indicates fat metabolism disturbances (diabetes, starvation, vomiting).
Bilirubin:
Principle: diazo reaction; indicates liver disease and bile duct obstruction; bilirubin must be conjugated to appear in urine.
Ictotest (confirmatory): uses tablets to produce blue color if bilirubin is present.
Urobilinogen:
Principle: Ehrlich reaction (p-dimethylaminobenzaldehyde) – normal urine contains trace amounts; elevated in hemolysis, liver disease; absence suggests biliary obstruction.
Tests: Ehrlich tube test, Watson-Schwartz test, etc.
Nitrite:
Principle: Greiss reaction; detects nitrate-reducing bacteria (e.g., Enterobacteriaceae); positive results support UTI; false negatives possible if bacteria do not reduce nitrate or if specimen is taken early.
Leukocyte esterase (LE):
Principle: esterase from granulocytes (neutrophils, eosinophils, monocytes) reacts to form a purple azodye; indicates pyuria and possible infection; often accompanied by bacteriuria.
Specific Gravity (SG) – SG estimation via pKa indicator change:
Indicator: Bromthymol blue; SG ranges from ~1.000 to ~1.030; higher SG leads to color changes toward yellow; low SG toward blue.
Clinical relevance: hydration status, renal concentrating ability, and diabetes insipidus assessment.
Osmolality:
Measured by osmolality meters or calculated; reflect particle number and solute concentration in urine.
V. Microscopic Examination of Urine
When to perform: microscopic analysis follows abnormal gross appearance, dipstick abnormalities, or when microscopic sediment is suspected.
Specimen volume: typically 12 mL (10–15 mL acceptable).
Specimen prep: examine fresh or properly preserved; formed elements (RBCs, WBCs, hyaline casts) disintegrate in dilute alkaline urine; refrigerations can cause amorphous sediment precipitation; warming to 37°C may dissolve crystals.
Volume of sediment examined: standard ~20 μL on a glass slide with a 22×22 mm cover slip; examine a minimum of 10 fields under 10× and 40× (low and high power).
Reported findings:
Casts: reported as average per 10 LPF (low power field).
RBCs/WBCs: reported as average per 10 HPF (high power field).
Epithelial cells, crystals, and other elements: semi-quantitative (rare, few, moderate, many) or 1+, 2+, 3+, 4+ per HPF or LPF.
Sediment stains and techniques:
Sternheimer-Malbin stain; Sedi-stain; KOVA stain.
Toluidine blue (metachromatic) – enhances nuclear details.
2% acetic acid – lyses RBCs; aids WBC identification.
Lipid stains: Oil Red O, Sudan III – identify triglycerides and fats; do not stain cholesterol.
Gram stain – bacteria differentiation.
Hansel stain – urinary eosinophils.
Wright’s stain – dried smears or sediments.
Prussian blue – iron-containing structures (e.g., hemosiderin).
Sediment constituents and clinical significance:
Cells: RBCs (0–3/HPF normals); WBCs (0–5/HPF normal); epithelial cells (squamous, transitional, renal tubular epithelial cells – RTE).
RBCs: dysmorphic RBCs suggest glomerular bleeding; RBC casts indicate glomerular-origin bleeding;
WBCs: neutrophils (predominant in infection), eosinophils (drug-induced interstitial nephritis), mononuclear cells (lymphocytes, monocytes, macrophages, histiocytes).
Epithelial cells: Squamous (vaginal/urethral contamination); Transitional (ureter, bladder, renal pelvis); Renal tubular epithelial (RTE) cells – most clinically significant: indicate tubular injury when >2/HPF.
Lipid-containing cells: Oval fat bodies; Maltese cross with Sudan stains; indicate lipiduria, nephrotic syndrome.
Casts: formed in distal tubules/collecting ducts; hyaline, granular, waxy, fatty, RBC, WBC, epithelial, bacterial casts; distribution and abundance reflect tubular pathology and type of renal disease (pyelonephritis, nephrotic syndrome, acute tubular necrosis, etc.).
Crystals: Normal and abnormal crystals seen; interpretations depend on pH (acid/alkaline), solubility, and birefringence; important abnormal crystals include cystine, tyrosine, leucine, bilirubin, cholesterol; urates (amorphous urates, uric acid crystals); calcium oxalate (envelope/dihydrate, monohydrate); triple phosphate (coffin lid); calcium phosphate; cystine crystals; and others (ampicillin, sulfonamides, radiographic contrast, etc.).
Crystals – practical memory aids:
Normal crystals in acidic urine: calcium oxalate (dihydrate envelope; monohydrate; etc.), uric acid, amorphous urates, acid urates.
Normal crystals in alkaline urine: amorphous phosphates, triple phosphates (struvite), calcium carbonate, calcium phosphate.
Abnormal crystals (metabolic or drug-related): tyrosine, leucine, cystine, bilirubin, cholesterol, various drug crystals (sulfonamides, ampicillin, radiographic dyes).
Urine pH, odor, and color changes: dips into the color-odor correlation; common drug-related color changes include yellow, orange, brown, etc., with specific drug associations.
D. Urine Preservation and Transportation Methods
Preservation methods (common):
1) Refrigeration – inhibits bacterial growth for ~24 hours; advantages: preserves chemical tests; disadvantages: raises SG by hydrometer and can precipitate amorphous sediments.
2) Thymol – preserves glucose and sediments; disadvantages: interferes with acid precipitation.
3) Boric acid – maintains pH ~6.0; preserves protein and formed elements; may interfere with some chemical analyses; can impede drug/hormone assays; disadvantage: may precipitate crystals in large amounts.
4) Formalin – excellent sediment preservative; reduces interference with some tests; disadvantages: reduces certain chemical tests (glucose, blood, leukocytes, copper reduction) due to reducing properties.
5) Toluene – nonaqueous preservative; does not interfere with routine tests but can float on urine surface and cling to plastics.
6) Sodium fluoride – prevents glycolysis; preserves for drug analysis; may inhibit glucose, blood, leukocyte tests; sometimes replaced with sodium benzoate.
7) Phenol – preserves sediments but changes odor; not ideal for all tests.
8) Commercial preservative tablets – convenient when refrigeration isn't possible; may contain fluoride.
9) Saccomanno fixative (50% ethanol + 2% carbowax) – used for cytology studies (~50 mL urine).
E. Urine Specimen Handling, Collection Techniques, and Special Procedures
Specimen collection considerations:
First morning, random, 24-hour, 12-hour timed collections.
For 24-hour collections, begin with an empty bladder; discard the first morning specimen; collect all urine for the next 24 hours; avoid overcollection by including only the timed portion after the first void.
Prostatitis specimen (three-glass collection) for localization: analyze VB1, VB2, VB3; 3rd specimen is compared to first; if 3rd is 10× greater than 1st for WBCs and bacteria, prostatitis suspected; 2nd specimen serves as control for bladder/kidney infection.
Pre- & Post-Massage Test (PPMT): clean-catch midstream collection with prostatic massage; three samples collected and analyzed for bacteriuria; a significant rise in bacteria in the 3rd sample (>10× that of 2nd) supports prostatitis.
Drug testing specimen considerations:
Documentation for proper sample identification; temperature control 32.5–37.7°C; blueing agent added to toilet water reservoir for unwitnessed collection; required volume 30–45 mL (often 60 mL).
F. Urinalysis in Disease Contexts
Urinalysis as a broad diagnostic tool:
Abnormal urine findings often reflect systemic or localized renal/urinary disorders.
Dipstick and microscopic analyses provide rapid information for patient management.
G. Urine Color and Odor Correlations (Color Chart and Drugs)
Urine color variations and common drug associations:
Colorless: dilution or diabetes insipidus; diabetes mellitus may show concentrated color with positive glucose.
Dark yellow/amber: dehydration; fever; burns; bilirubin (yellow foam).
Orange/red: rifampin; phenazopyridine usage; vitamin supplements; ATB-related pigments.
Yellow-green: indican; certain antidepressants.
Blue-green: indica, amitriptyline; methocarbamol.
Pink/red: hematuria; intravascular hemolysis; myoglobinuria; menstrual contamination.
Brown/black: old samples; porphyrins; melanins; certain drugs.
H. Specific Clinical Highlights in Urinalysis
Glomerular vs tubular disease clues:
Dysmorphic RBCs and RBC casts point to glomerular disease.
RBC casts indicate glomerular bleeding; WBC casts indicate pyelonephritis or nephritis; granular casts indicate tubular damage.
Proteinuria categories (overview):
Prerenal/overflow proteinuria (e.g., Bence Jones protein in multiple myeloma).
Renal (glomerular or tubular) proteinuria – includes microalbuminuria in diabetics.
Post-renal proteinuria due to urinary tract inflammation or bleeding.
Microalbuminuria screening for diabetic nephropathy:
Tests: Micral immunochemical assay, ImmunoDip; AER (albumin excretion rate) thresholds: 0–20 μg/min normal; 20–200 μg/min microalbuminuria; >200 μg/min clinical albuminuria.
Albumin/creatinine ratio (ACR) used to correct for urine concentration.
I. Amniotic Fluid Analysis (Amniotic Fluid Testing)
Functions of amniotic fluid: cushion, fetal movement, temperature regulation, fetal lung development; fetal urine contributes to AF composition.
Key analytes and comparisons with maternal urine:
Protein: present in AF; glucose: typically present? (negative in maternal urine, AF can show different patterns)
Urea: AF < 30 mg/dL; maternal urine > 300 mg/dL.
Creatinine: AF < 3.5 mg/dL; maternal urine > 10 mg/dL.
Specimen collection and handling:
Amniocentesis (sample volume up to 30 mL); performed after 14 weeks.
Volume patterns: ~35 mL in 1st trimester; increases to ~1 L by 3rd trimester.
Tests for fetal well-being and anomalies:
Fern test for ruptured membranes.
Fetal distress: Liley graph (spectrophotometry of hemolysis) and 450 nm absorbance difference (A450);
AFP (alpha-fetoprotein) immunoassays; neural tube defects detection (NTD) and Down syndrome risk; Acetylcholinesterase as confirmatory test for NTD; different screening panels including FLM indices (L/S ratio, PG, lamellar bodies).
L/S ratio and PG (phosphatidylglycerol):
L/S ratio > 2.0 indicates mature fetal lungs; PG presence supports maturity; testing by TLC or immunoassays.
Lamellar bodies, foam stability index, microviscosity, and other mature lung indicators used with multiple modalities.
I. Feces (Stool) Analysis
Physiology:
Normal stool contains bacteria, cellulose, undigested food, bile pigments, cells, electrolytes, water.
Typical daily stool weight varies; normal GI content ~100–200 g/day.
Diagnostic aims:
Detect GI bleeding, liver/biliary/pancreatic disorders, malabsorption/maldigestion, diarrhea etiologies, inflammatory disorders.
Diarrhea characterization:
Illness duration, mechanism, severity; stool characteristics categorized (Acute vs chronic; watery, fat-laden, bloody, etc.).
Fecal testing overview:
Fecal electrolytes and osmolality; fecal osmolarity and osmotic gap calculation:
Osmotic gap = ${290}$ – $2 imes ( ext{fecal Na} + ext{fecal K})$ (mOsm/kg).
Osmotic diarrhea: osmolar gap > 50 mOsm/kg; electrolytes minimal.
Secretory diarrhea: osmolar gap < 50 mOsm/kg; electrolytes elevated.
Major Stool Parameters:
Steatorrhea: quantitative fat excretion (>6 g/day) or qualitative with Sudan III staining; tests include qualitative fat staining and quantitative fecal fat analyses (Van de Kamer titration, NMR-based methods).
Fecal leukocytes: >3 neutrophils/HPF indicates invasive bacterial infection (e.g., Salmonella, Shigella, Campylobacter); lactoferrin latex agglutination test as alternative.
Fecal fat: use Sudan staining (direct smear) or Sudan II/III; Oil Red O for lipids; fat droplets indicate malabsorption/maldigestion.
Fecal enzymes: pancreatic elastase I (most specific marker of pancreatic insufficiency); fecal chymotrypsin; trypsin; measured by ELISA or colorimetric methods.
Carbohydrates in stool: reducing substances detected by copper reduction test (Clinitest) indicate disaccharidase deficiency and malabsorption.
D-Xylose test for malabsorption (low levels indicate malabsorption).
Microscopic fecal examination:
Fecal leukocytes, undigested muscle fibers, and fats in stool indicate invasive disease (e.g., inflammatory bowel disease) or pancreatic insufficiency.
Muscle fiber analysis: eosin-stained smear to visualize muscle fiber; >10 undigested fibers indicate pancreatic insufficiency.
Qualitative fecal fats: direct smear stained with Sudan III; heated with acetic acid and Sudan III for split fat test; amount indicates steatorrhea.
Other considerations:
Occult blood testing for feces (guaiac-based and immunochemical tests) – detect hidden GI bleeding; porphyrin-based tests also discussed.
Pancreatic enzyme testing (elastase I, chymotrypsin) as markers of pancreatic exocrine function.
J. Semen (Semen Analysis) – Male Reproductive Fluids
Physiology:
Semen comprises contributions from the epididymis, seminal vesicles, prostate, and bulbourethral glands.
Normal semen volume, composition, and pH essential for sperm function and fertilization.
Definitions:
Aspermia: no ejaculate
Azoospermia: no sperm in semen
Oligospermia: reduced sperm concentration
Varicocele: dilation of testicular veins; a common infertility cause
Anatomy & components:
Testes: seminiferous tubules produce sperm; Sertoli cells support germ cells; Spermatogenesis takes about 90 days, with maturation in the epididymis.
Ducts: vas deferens transports sperm; ejaculatory ducts receive seminal vesicle fluid; sperm then combine with prostatic fluid and bulbourethral fluid.
Seminal vesicles produce fructose-rich fluid supplying energy to sperm; prosthetic fluid is milky and acidic; bulbourethral glands add alkaline mucus to neutralize vaginal acidity.
Semen composition:
5% spermatozoa; 5% seminal fluid; 60–70% prostate fluid; 20–30% bulbourethral gland secretions; 5% spermatozoa.
Specimen collection guidelines:
Complete specimen; 3 days abstinence; avoid urine in the sample; typical semen collected via masturbation; avoid lubricants containing spermicides.
If the first portion is missing, sperm count may be low and pH may be falsely elevated; last portion missing can reduce volume and affect analysis; semen samples should be tested within 1 hour.
Physical and biochemical properties:
Appearance: gray-white, translucent, musty odor; color may indicate contamination or infection.
Volume: normal range ~2–5 mL; viscosity: low viscosity indicates good liquefaction; prolonged undissolved semen indicates prostatitis or enzymatic deficiency; liquefaction should occur within 30–60 minutes; if not liquefied, add proteolytic enzymes (e.g., chymotrypsin) or Dulbecco’s buffer.
pH: normal 7.2–8.0; deviations suggest infection or prostatic issues.
Sperm count: normal >40 million per ejaculate; concentration >20 million/mL; total sperm count = concentration × volume; motility: forward progression is essential; WHO grading 0–4 or A–D depending on system; progressive motility indicates fertility potential.
Morphology: Kruger strict criteria normal forms >14%; overall normal forms >30% often cited; abnormalities in head, neck, midpiece, tail affect fertilization.
Vitality: viability >50% living cells; assessed with eosin-nigrosin stain.
Sperm function tests: hamster egg penetration, cervical mucus penetration, hypo-osmotic swelling (membrane integrity), in vitro acrosome reaction, etc.
Immunology and infections:
Antisperm antibodies (ASA): present in both genders; MAR and immunobead tests detect anti-sperm antibodies.
Post-vasectomy testing: semen analysis monthly for several months to confirm azoospermia or absence of sperm.
Post-coital testing and ABO/DNA tests for forensic/forensic contexts.
Semen chemistry and markers:
Fructose: produced by seminal vesicles; low fructose suggests vesicle or duct obstruction or absence; fructose detected by resorcinol test; normal levels >13 μmol/ejaculate.
Neutral α-glucosidase, glycerophosphocholine, L-carnitine: markers of epididymal function; zinc and citric acid levels reflect prostatic fluids; marker tests help differentiate prostatic vs seminal vesicle abnormalities.
Post-coital and forensic semen testing:
Detecting semen presence: phase-contrast microscopy; Xylene-enhanced slides; PSA glycoprotein p30 as a specific marker; ABO blood grouping and DNA analysis can be used.
K. Cerebrospinal Fluid (CSF) – Basic and Diagnostic Aspects
Functions: provides nutrients to CNS; removes metabolic wastes; cushions brain and spinal cord.
Anatomy and production:
Meninges (dura, arachnoid, pia); choroid plexuses produce CSF via selective filtration; CSF located in subarachnoid space; reabsorption via arachnoid granulations into venous blood.
Total CSF volume ≈ 90–170 mL in adults; neonates have less; turnover is continuous; CSF production rate ≈ 20 mL/h per standard sources.
CSF collection and handling:
Lumbar puncture is common; CSF tubes designated for microbiology, hematology, chemistry in order of testing.
Specimens: keep on ice for culture; room temperature for cytology; freeze if required; avoid contamination.
CSF tests:
Direct cell count and differential: Expect predominance of lymphocytes/monocytes in viral infections; neutrophils in bacterial meningitis; erythroblasts in intracranial hemorrhage; NRBCs may indicate bone marrow contamination.
Total protein: elevated in meningitis and inflammatory conditions; oligoclonal bands and albumin quotient used to assess blood-brain barrier integrity (BBB).
Glucose: normally ~60% of serum glucose; low CSF glucose with bacterial/fungal meningitis; higher CSF glucose generally means viral meningitis.
CSF lactate: elevated in bacterial meningitis, tubercular meningitis; normal in viral meningitis.
CSF adenosine deaminase (ADA): elevated in tubercular meningitis.
Enzymes: LDH patterns; CK-BB, AST, and others may reflect CNS pathology.
Immunologic and microbiologic studies: Gram stain, culture, Limulus amebocyte lysate (LAL) for endotoxins, PCR for pathogens, latex agglutination tests, and antigen tests (e.g., cryptococcal antigen).
Oligoclonal bands and IgG index: used to diagnose multiple sclerosis and other inflammatory CNS diseases; IgG index >0.70 suggests intrathecal IgG synthesis.
Differential diagnosis in CSF:
Bacterial meningitis: high protein, low glucose, high CSF lactate, predominant neutrophils, positive Gram stain.
Viral meningitis: mild-to-moderate protein elevation, normal/slightly decreased glucose, lymphocytic predominance.
Tubercular meningitis: elevated protein, low glucose, high LDH, ADA; characteristic cell patterns; TB PCR/acid-fast staining support.
Fungal meningitis: variable protein/glucose with lymphocytic predominance; cryptococcal antigen testing important.
L. Synovial Fluid (Joint Fluid)
Functions: lubrication, nutrient supply to articular cartilage, reduces joint friction and shock.
Physiology:
Synovial fluid is a viscous ultrafiltrate of plasma containing hyaluronic acid and small amounts of protein; produced by synoviocytes.
Normal volume in a diarthrodial joint is small; excess fluid indicates inflammation or injury (effusion).
Classification of arthritis (by fluid analysis):
I. Non-inflammatory degenerative (osteoarthritis) – mild inflammation; viscosity relatively preserved; WBC count low.
II. Inflammatory (rheumatoid arthritis, SLE, gout/pseudogout) – higher WBC counts; decreased viscosity; PMN predominant in septic/crystal-induced arthritis.
III. Septic – infection with high WBC, neutrophil predominance; possible bacteria on Gram stain/culture.
IV. Hemorrhagic – traumatic injury or coagulopathy; bloody fluid.
Specimen handling and tests:
Volume typically ~0.5–2.0 mL; collect via arthrocentesis with sterile technique.
Color: clear to yellow; dark yellow indicates inflammation; greenish suggests infection.
Viscosity: measured for mucin clot formation (mucin clot test); higher viscosity correlates with hyaluronic acid content.
Glucose: usually ~70–110 mg/dL; decreased in inflammatory/septic arthritis.
Protein: normally <3 g/dL; higher in inflammatory or hemorrhagic conditions.
Uric acid and lactate: elevated in gouty and septic arthritis; lactate higher in septic arthritis.
Microbiology and cytology:
Gram stain and culture for bacteria; special stains and flow cytometry for tumor cells when suspicious.
Serologic testing for RF/SLE and other autoimmune markers when indicated.
Lyme disease testing in suspected Lyme arthritis.
Crystal examination:
Identification of crystals (urates and phosphates) using polarized light and compensated light; negative birefringence for monosodium urate (MSU) crystals; positive birefringence for calcium pyrophosphate dihydrate (CPPD) crystals (pseudogout).
Polarized light microscopy difference between MSU and CPPD crystals is key for differential diagnosis.
M. Serous Fluids (Pleural, Pericardial, Peritoneal Fluids)
General functions: serous fluids lubricate membranes in closed body cavities (pleural, pericardial, peritoneal).
Formation and dynamics:
Ultrafiltrate of plasma; production and reabsorption governed by oncotic and hydrostatic pressures (Starling forces).
Effusion arises when formation and reabsorption balance is disrupted.
Transudates vs Exudates:
Transudates: systemic disorders causing abnormal hydrostatic/oncotic forces (e.g., CHF, cirrhosis, nephrotic syndrome). Low protein and LDH; low SG.
Exudates: local membrane diseases (infections, malignancies, inflammatory conditions). Higher protein and LDH; increased cell counts.
Diagnostic differentiation of effusions:
Fluid-to-serum protein and LDH ratios; LDH in fluid and serum; Rivalta’s test (serosum mucin clot test) – negative in transudates, positive in exudates (historical test).
Specific gravity (SG), glucose, pH, LDH, and cell counts helpful in distinguishing transudates from exudates.
Cell counts and differential are performed; cytology helps identify malignant cells.
Pleural fluid cholesterol and cholesterol ratio to serum help differentiate chylous effusions from hemorrhagic effusions; triglycerides differentiate chylous from pseudochylous effusions.
Pleural fluid cytology and microbiology:
Cytology to identify malignant cells; flow cytometry and tumor markers (CA 125, CEA, CA 19-9, CA 15-3, CYFRA 21-1) can be adjuncts.
Bacterial cultures and Gram stains for infectious etiologies; PCR and other molecular tests used in specific contexts.
Pericardial and peritoneal fluids:
Similar QA/QA; pericardial fluid analysis includes cytology for malignant cells, ADA for TB; tumor markers; microbiology testing.
SAAG (serum-ascites albumin gradient) used to differentiate hepatic ascites (transudate) from exudative etiologies in ascites.
N. Amniotic Fluid – Additional Details
Fern test: detects ruptured fetal membranes; a fern-like crystal pattern indicates rupture.
AFP testing and Alpha-fetoprotein: elevated in open neural tube defects; used for NTD screening; confirmation with acetylcholinesterase assay.
Fetal lung maturity (FLM) testing:
L/S ratio > 2.0 indicates mature lungs; L/S ratio is measured by thin-layer chromatography.
Phosphatidylglycerol (PG) presence confirms maturity; Amniostat-FLM method (immunoassay) detects PG.
Foam Stability Index, Microviscosity, Lamellar Body count, OD 650 nm, and other indices (Lamellar bodies > 32,000/μL indicate mature lungs; lower values indicate immaturity).
Sample collection: amniocentesis; sample volumes vary by gestational age; volumes peak in the third trimester (~1 L).
Color and appearance of AF:
Colorless to yellow; yellow-green indicates meconium; dark green indicates the presence of bile pigments; turbidity indicates infection or inflammation.
Fetal distress assessment: Liley’s graph (hemolysis index) based on 450 nm absorbance.
O. Porphyrin and Inborn Errors of Metabolism (Overview)
Major disorders involve heme synthesis disorders (porphyrias) and amino acid disorders.
Screening tests (overview): ferric chloride tube test, Ehrlich reaction tests (Watson-Schwartz), Tin/Acetyl tests, Clinitest, DS tests for 5-HIAA, and porphyrin metabolites in urine, feces, and blood.
Common disorders discussed:
Phenylketonuria (PKU): phenylalanine hydroxylase deficiency; phenylalanine buildup leads to phenylpyruvic acid in urine; screening with ferric chloride; Guthrie test; confirm with chromatography or tandem MS.
Tyrosinemia (Type 1–3): tyrosine metabolic defects; tyrosine and its metabolites in urine; liver disease signs.
Alkaptonuria: homogentisic acid accumulation; urine darkens on standing; ferric chloride and other tests detect hydroxyindole derivatives.
Melanuria and Melanin-related disorders: melanin/related metabolites excreted in urine; ferric chloride and nitroprusside-based tests used in screening.
Maple syrup urine disease (MSUD): branched-chain amino acids (leucine, isoleucine, valine) and corresponding keto acids; detection via DNPH test; newborn screening essential.
Porphyrias: progressive disruptions in heme synthesis; screening by Ehrlich reaction and fluorescent tests; Hoesch test detects porphobilinogen; lead exposure is a contributing factor in some porphyrias.
P. Summary of Core Formulas and Key Values
Glomerular filtration rate (GFR): about (adult, average baseline).
Creatinine clearance (Ccr) formula (example):
where $U{cr}$ is urine creatinine, $V$ is urine flow rate, and $P_{cr}$ is plasma creatinine.
Cockcroft–Gault estimate (creatinine clearance):
Osmolality: direct vs indirect methods; 275–295 mOsm/kg serum; 300–900 mOsm/kg urine over 24 h; osmolality elevations indicate concentrating ability changes.
Albuminuria and albumin-to-creatinine ratio (ACR) thresholds:
Microalbuminuria: 20–200 μg/min or 30–300 mg/g creatinine.
Clinical albuminuria: >200 μg/min or >300 mg/g creatinine.
A general understanding of proteinuria types and their clinical implications:
Pre-renal overflow proteinuria (e.g., light chains in myeloma).
Glomerular (true renal disease) proteinuria.
Tubular (Fanconi syndrome) proteinuria.
Urine crystals (examples):
Normal acid urine: calcium oxalate (envelope or dumbbell shapes), uric acid crystals.
Normal alkaline urine: ammonium phosphate (struvite), triple phosphate.
Abnormal crystals: tyrosine, leucine, cystine, cholesterol, bilirubin, among others; specific appearances aid diagnosis.
Notes and References for Exam Preparation
Urinalysis is a foundational lab test that integrates gross, chemical, and microscopic assessments to aid in diagnosis and monitoring of disease.
The nephron’s structural and functional components (glomerulus, PCT, Loop of Henle, DCT, collecting duct) are central to understanding urine formation, solute handling, and urine concentration.
Safety, QA, and specimen handling are critical to ensure reliable results and patient safety in the laboratory.
The exam may test formulas (GFR, clearance, Cr%), interpretation of dipstick results, identification of sediment components, and the clinical implications of findings in kidney, urinary tract, liver, GI, reproductive, and CNS fluids.
Real-world relevance includes monitoring for nephropathy in diabetes, evaluating renal transplant rejection, diagnosing UTIs, evaluating therapeutic responses, and assessing fetal health via amniotic fluid analysis.
Quick Reference Tables (Key Points)
Urine Collection Types:
First morning: concentrated; routine screening; orthostatic proteinuria evaluation.
Random: routine screening.
24-hour: quantitative chemical tests; requires preservatives; begin/end with empty bladder.
Prostate testing: three-glass collection (VB1, VB2, VB3) and PPMT.
Basic Urinalysis vs Microscopy:
Dipstick: pH, protein, glucose, ketones, blood, bilirubin, urobilinogen, nitrite, leukocyte esterase, SG.
Microscopy: RBCs, WBCs, epithelial cells, casts, crystals, lipids, bacteria, yeast, parasites, sperm.
NA/LS: Typical RBC/WBC counts in urine:
RBCs: 0–3/HPF (normal)
WBCs: 0–5/HPF (normal)
Nephrotic syndrome indicators:
Massive proteinuria (>3.5 g/day), hypoalbuminemia, hyperlipidemia, edema, lipiduria.
Fetal lung maturity indices (selected):
L/S ratio > 2.0; presence of PG; FLM indices (foam stability, microviscosity, lamellar bodies) indicating maturity.
Porphyrin disorders – screening panels include Ehrlich reaction, Hoesch test, Watson-Schwartz test, and specific porphyrin metabolite analyses.
If you’d like, I can tailor these notes to a specific exam format (e.g., outline-only, flashcards, or a condensed version focusing on high-yield facts). Also tell me if you want the notes exported in a different structure or with additional worked examples.